IL86542A - A method for detecting a tendency to retinoblastoma and a method for detecting a retinoblastoma gene that is damaged in tumors using a detector that is a retinoblastoma gene - Google Patents

A method for detecting a tendency to retinoblastoma and a method for detecting a retinoblastoma gene that is damaged in tumors using a detector that is a retinoblastoma gene

Info

Publication number
IL86542A
IL86542A IL8654288A IL8654288A IL86542A IL 86542 A IL86542 A IL 86542A IL 8654288 A IL8654288 A IL 8654288A IL 8654288 A IL8654288 A IL 8654288A IL 86542 A IL86542 A IL 86542A
Authority
IL
Israel
Prior art keywords
retinoblastoma
probe
dna
tumor
gene
Prior art date
Application number
IL8654288A
Other languages
English (en)
Hebrew (he)
Other versions
IL86542A0 (en
Original Assignee
Canji Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canji Inc filed Critical Canji Inc
Publication of IL86542A0 publication Critical patent/IL86542A0/xx
Publication of IL86542A publication Critical patent/IL86542A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Graft Or Block Polymers (AREA)
IL8654288A 1987-05-29 1988-05-29 A method for detecting a tendency to retinoblastoma and a method for detecting a retinoblastoma gene that is damaged in tumors using a detector that is a retinoblastoma gene IL86542A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878712646A GB8712646D0 (en) 1987-05-29 1987-05-29 Structural evidence

Publications (2)

Publication Number Publication Date
IL86542A0 IL86542A0 (en) 1988-11-15
IL86542A true IL86542A (en) 1994-02-27

Family

ID=10618110

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8654288A IL86542A (en) 1987-05-29 1988-05-29 A method for detecting a tendency to retinoblastoma and a method for detecting a retinoblastoma gene that is damaged in tumors using a detector that is a retinoblastoma gene

Country Status (18)

Country Link
EP (2) EP0293266A3 (no)
JP (1) JPH04500751A (no)
KR (1) KR960002560B1 (no)
AT (1) ATE86673T1 (no)
AU (2) AU1983188A (no)
DE (1) DE3879208T2 (no)
DK (1) DK675088D0 (no)
ES (1) ES2054880T3 (no)
FI (1) FI895364A0 (no)
GB (1) GB8712646D0 (no)
GR (1) GR3007474T3 (no)
IE (1) IE62296B1 (no)
IL (1) IL86542A (no)
NO (1) NO301774B1 (no)
NZ (1) NZ224822A (no)
PT (1) PT87614B (no)
WO (1) WO1988009387A1 (no)
ZA (1) ZA883805B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341576C (en) * 1986-08-11 2008-07-08 Thaddeus P. Dryja Diagnosis of retinoblastoma
US7223842B1 (en) 1986-08-11 2007-05-29 Massachusetts Eye And Ear Infirmary Detection of proteins whose absence is associated with a neoplasm
US5853988A (en) * 1986-08-11 1998-12-29 Massachusetts Eye And Ear Infirmary Diagnosis of retinoblastoma
US7384735B1 (en) 1986-08-11 2008-06-10 Massachusetts Eye And Ear Infirmary Retinoblastoma nucleic acids
EP0264274A3 (en) * 1986-10-14 1989-02-01 Canon Kabushiki Kaisha Optical recording medium
US5268267A (en) * 1987-08-21 1993-12-07 The General Hospital Corporation Method for diagnosing small cell carcinoma
JP3163090B2 (ja) * 1988-01-21 2001-05-08 マサチューセッツ アイ アンド イヤー インファーマリー 網膜芽腫診断剤
EP0390323B2 (en) * 1989-03-29 2012-08-08 Johns Hopkins University Detection of loss of the wild-type p53 gene
CA2060267A1 (en) * 1991-02-22 1992-08-23 Joe W. Gray Chromosome specific staining to detect genetic rearrangements
AU673813B2 (en) * 1991-11-14 1996-11-28 Qiagen Gaithersburg, Inc. Non-radioactive hybridization assay and kit
WO1994008049A1 (en) * 1992-10-01 1994-04-14 The General Hospital Corporation Functional assay for tumor suppressor genes
JPH06296489A (ja) * 1992-11-20 1994-10-25 Univ Texas Syst 網膜芽腫−関連タンパク質をコードする細胞性遺伝子
US5496731A (en) * 1993-03-25 1996-03-05 Xu; Hong-Ji Broad-spectrum tumor suppressor genes, gene products and methods for tumor suppressor gene therapy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341576C (en) * 1986-08-11 2008-07-08 Thaddeus P. Dryja Diagnosis of retinoblastoma

Also Published As

Publication number Publication date
EP0364490A1 (en) 1990-04-25
EP0364490A4 (en) 1990-05-14
WO1988009387A1 (en) 1988-12-01
DK675088A (da) 1988-12-02
PT87614A (pt) 1988-06-01
IE881613L (en) 1988-11-29
DE3879208T2 (de) 1993-07-22
EP0293266A2 (en) 1988-11-30
AU657143B2 (en) 1995-03-02
EP0293266A3 (en) 1990-04-11
EP0364490B1 (en) 1993-03-10
DK675088D0 (da) 1988-12-02
JPH04500751A (ja) 1992-02-13
ATE86673T1 (de) 1993-03-15
GR3007474T3 (no) 1993-07-30
AU1983188A (en) 1988-12-21
NO301774B1 (no) 1997-12-08
NO885712L (no) 1988-12-22
NZ224822A (en) 1989-12-21
KR890701763A (ko) 1989-12-21
ES2054880T3 (es) 1994-08-16
AU2038292A (en) 1992-09-24
IE62296B1 (en) 1995-01-25
IL86542A0 (en) 1988-11-15
GB8712646D0 (en) 1987-07-01
PT87614B (pt) 1993-03-31
ZA883805B (en) 1990-11-28
FI895364A0 (fi) 1989-11-10
KR960002560B1 (ko) 1996-02-22
NO885712D0 (no) 1988-12-22
DE3879208D1 (de) 1993-04-15

Similar Documents

Publication Publication Date Title
Chen et al. Deletion, mutation, and loss of expression of KLF6 in human prostate cancer
van Deutekom et al. Identification of the first gene (FRG1) from the FSHD region on human chromosome 4q35
German Consortium for Hereditary Breast and Ovarian Cancer Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population
Bowl et al. An interstitial deletion-insertion involving chromosomes 2p25. 3 and Xq27. 1, near SOX3, causes X-linked recessive hypoparathyroidism
Albrecht et al. Spectrum of gross deletions and insertions in the RB1 gene in patients with retinoblastoma and association with phenotypic expression
Pollock et al. PTEN inactivation is rare in melanoma tumours but occurs frequently in melanoma cell lines
EP0730648B1 (en) HUMAN MUTATOR GENE hMSH2 AND HEREDITARY NON POLYPOSIS COLORECTAL CANCER
IL86542A (en) A method for detecting a tendency to retinoblastoma and a method for detecting a retinoblastoma gene that is damaged in tumors using a detector that is a retinoblastoma gene
US5306616A (en) Molecular diagnosis of autosomal dominant charcot-marie-tooth disease
CA2312273A1 (en) Cancer susceptibility mutations of brca1
Hall et al. Oncogenes and human breast cancer.
Walker et al. Simple tandem repeat allelic deletions confirm the preferential loss of distal chromosome 6q in melanoma
US5837443A (en) Diagnostic method employing MSH2 protein
Thomson et al. NF1 mutations and molecular testing
Posteraro et al. Laminin-5 mutational analysis in an Italian cohort of patients with junctional epidermolysis bullosa
US20120207755A1 (en) Cancer
Opdecamp et al. The rat microphthalmia-associated transcription factor gene (Mitf) maps at 4q34-q41 and is mutated in the mib rats
Pulkkinen et al. Detection of novel LAMC2 mutations in Herlitz junctional epidermolysis bullosa
US5773649A (en) DNA markers to detect cancer cells expressing a mutator phenotype and method of diagnosis of cancer cells
Champeme et al. Association between restriction fragment length polymorphism of the L‐myc gene and lung metastasis in human breast cancer
Komminoth et al. Molecular diagnosis of multiple endocrine neoplasia (MEN) in paraffin-embedded specimens
US5556786A (en) Anhidrotic ectodermal dysplasia gene and method of detecting same
US5770372A (en) Detection of mutations in the human ATM gene
CA2308766C (en) Diagnostic assay for cancer susceptibility
Kayes et al. The gene for a novel epidermal antigen maps near the neurofibromatosis 1 gene